DNMT3A Arg882 mutation drives chronic myelomonocytic leukemia through disturbing gene expression/DNA methylation in hematopoietic cells

The gene encoding DNA methyltransferase 3A (DNMT3A) is mutated in ∼20% of acute myeloid leukemia cases, with Arg882 (R882) as the hotspot. Here, we addressed the transformation ability of the DNMT3A-Arg882His (R882H) mutant by using a retroviral transduction and bone marrow transplantation (BMT) approach and found that the mutant gene can induce aberrant proliferation of hematopoietic stem/progenitor cells. At 12 mo post-BMT, all mice developed chronic myelomonocytic leukemia with thrombocytosis. RNA microarray analysis revealed abnormal expressions of some hematopoiesis-related genes, and the DNA methylation assay identified corresponding changes in methylation patterns in gene body regions. Moreover, DNMT3A-R882H increased the CDK1 protein level and enhanced cell-cycle activity, thereby contributing to leukemogenesis..

Medienart:

E-Artikel

Erscheinungsjahr:

2014

Erschienen:

2014

Enthalten in:

Zur Gesamtaufnahme - volume:111

Sprache:

Englisch

Beteiligte Personen:

Xu, Jie [VerfasserIn]
Wang, Yue-Ying [VerfasserIn]
Dai, Yu-Jun [VerfasserIn]
Zhang, Wu [VerfasserIn]
Zhang, Wei-Na [VerfasserIn]
Xiong, Shu-Min [VerfasserIn]
Gu, Zhao-Hui [VerfasserIn]
Wang, Kan-Kan [VerfasserIn]
Zeng, Rong [VerfasserIn]
Chen, Zhu [VerfasserIn]
Chen, Sai-Juan [VerfasserIn]

Links:

Volltext

Themen:

Biological sciences
Health sciences
Physical sciences
Research-article

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

JST113733151